We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
The Competition and Markets Authority (CMA) has a statutory duty to comply with the Public Records Act 1958 (PRA).
An overview of the Competition and Markets Authority’s (CMA) recommendations following its market study into the legal services sector.
The CMA has today appointed its new General Counsel and Executive Director for Digital Markets.
After extensive engagement, the CMA has published its Annual Plan for 2024 to 2025.
Information about the CMA's coronavirus (COVID-19) taskforce.
Volume 42 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
The CMA has today published its main concerns following an initial review into the veterinary sector.
Volume 15 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Following a provisional clearance in February, the CMA is now allowing the proposed deal between Arçelik and Whirlpool to go ahead.
Volume 37 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
The investigation will consider whether Vifor Pharma has been engaging in anti-competitive conduct.
The CMA will not recommend renewing a ‘block exemption’, which provides an exemption from competition law for certain forms of cooperation between liner shipping companies.
Guidance on the CMA's approach to merger assessment during the coronavirus pandemic.
Guidance on how residents and relatives can inform the CMA about a consumer protection issue with a care home.
Volume 33 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Volume 22 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Volume 38 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Volume 23 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Volume 34 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.